Last Updated on September 23, 2021 by The Health Master
India expects to get its first Johnson & Johnson C-19 vaccine doses from next month, filled and finished in India by a partner of the US drugmaker, a source with knowledge of the matter told Reuters yesterday.
It could receive as many as 43.5 million doses of the single-shot vaccine in October, said the source – a big step towards helping India meet its target of producing more than 300 million doses in the month.
is the world’s biggest centre of vaccine manufacturing. Once it has met its own needs, it plans to resume exports, which it stopped in April.
India’s drug regulator last month gave emergency authorisation to the J&J vaccine, whether imported or locally filled and finished by Johnson & Johnson‘s Indian partner, Biological E.
However, the Indian government has not yet signed any supply deal with Johnson & Johnson .
“Johnson & Johnson doses are expected from next month,” said the source, who declined to be named as he was not authorised to talk to the media. “Bio E will do the formulation and make 5 ml vials.”
India’s health ministry did not immediately respond to a request for comment.
A Johnson & Johnson India spokesperson said it was “premature for us to speculate on the timing of our vaccine deliveries.”
ICPA donates Nasal Endoscopes Machine to KEMH’s ENT Dept
DCGI classifies 247 Medical Devices: Nephrology, Renal care etc.
IPC releases Guidance documents for Stakeholders: Download
Anti Counterfeit Technologies in Pharma & Medical Device packing
India and Pharmacy Education: Chapter: 8
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
